Tianjin CanSino Biotechnology Inc.

📍 Tianjin, China👥 18 employees💰 Last funded 2015
Biotechnology🌐 cansinotech.com
Website LinkedIn
Tianjin CanSino Biotech Inc. is an emerging biotechnology company dedicated to vaccine research, development and commercialization. We seek to address the pressing unmet medical needs by developing and marketing leading-edge, high quality vaccines for China and other emerging markets at affordable prices. CanSino has established bacterial and cell/viral culture pilot facilities in compliance to the current GMP standard. We can provide service to our clients and partners for clinical trial material production.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
China
1
Frequently asked questions
Who invested in Tianjin CanSino Biotechnology Inc.?
Tianjin CanSino Biotechnology Inc. has 1 investors on record on gritt.io.
When did Tianjin CanSino Biotechnology Inc. last raise funding?
The most recent investment in Tianjin CanSino Biotechnology Inc. recorded on gritt.io was in 2015.
What industry is Tianjin CanSino Biotechnology Inc. in?
Tianjin CanSino Biotechnology Inc. operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Tianjin CanSino Biotechnology Inc. based?
Tianjin CanSino Biotechnology Inc. is headquartered in Tianjin, China.